- $3.85m
- $14.92m
- $5.61m
Annual income statement for Intrusion, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 13.6 | 6.62 | 7.28 | 7.53 | 5.61 |
| Cost of Revenue | |||||
| Gross Profit | 8.3 | 3.91 | 3.66 | 4.17 | 4.35 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 9.14 | 13.1 | 26.8 | 23.4 | 17.7 |
| Operating Profit | 4.51 | -6.52 | -19.5 | -15.9 | -12 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 4.46 | -6.52 | -18.8 | -16.2 | -13.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4.46 | -6.52 | -18.8 | -16.2 | -13.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 4.46 | -6.52 | -18.8 | -16.2 | -13.9 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 4.33 | -6.6 | -18.8 | -16.2 | -13.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5.64 | -8.99 | -20.9 | -16.8 | -11.5 |